AWM
DNA icon

Activest Wealth Management’s Ginkgo Bioworks DNA Stock Holding History

Activest Wealth Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-38
Closed -$387 – 1091
2024
Q4 		$373 Hold
38
– – ﹤0.01% 564
2024
Q3 		$310 Sell
38
-1
-3% -$10 ﹤0.01% 503
2024
Q2 		$519 Hold
39
– – ﹤0.01% 458
2024
Q1 		$1.8K Hold
39
– – ﹤0.01% 308
2023
Q4 		$2.62K Hold
39
– – ﹤0.01% 256
2023
Q3 		$2.81K Hold
39
– – ﹤0.01% 253
2023
Q2 		$12.5K Hold
39
– – 0.01% 154
2023
Q1 		$1.91K Hold
39
– – ﹤0.01% 258
2022
Q4 		$2.62K Hold
39
– – ﹤0.01% 393
2022
Q3 		$5K Buy
39
+20
+105% +$2.38K ﹤0.01% 346
2022
Q2 		$2K Hold
19
– – ﹤0.01% 325
2022
Q1 		$3K Hold
19
– – ﹤0.01% 279
2021
Q4 		$6K Buy
+19
New +$9.03K ﹤0.01% 243

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Activest Wealth Management's DNA Position: Q1 2025 in Review

Activest Wealth Management sold out of Ginkgo Bioworks (DNA) in Q1 2025, closing a stake of 38 shares — an estimated $387 sold.

Activest Wealth Management first reported a position in DNA in Q4 2021 and held it in 13 quarters. The position peaked at $12.5K in Q2 2023. 167 funds tracked by Wall St. Rank hold DNA as of Q1 2025.

  • Activest Wealth Management reported no remaining Ginkgo Bioworks position as of Q1 2025 after selling out during the quarter.
  • Activest Wealth Management sold 38 Ginkgo Bioworks shares in Q1 2025, an estimated $387.
  • Activest Wealth Management first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 13 quarters.
  • Activest Wealth Management's Ginkgo Bioworks position peaked at $12.5K in Q2 2023.
  • 167 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2025.

Based on Activest Wealth Management's 13F filing for Q1 2025, filed 15 May 2025.